{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:40:56Z","timestamp":1787229656694,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.lanwpc.2024.101077","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T19:14:44Z","timestamp":1714418084000},"page":"101077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Improvements in the health-related quality-of-life benefit of cancer drugs approved in China, 2005\u20132020: an observational study"],"prefix":"10.1016","volume":"46","author":[{"given":"Lan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangqianyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-3827","authenticated-orcid":false,"given":"Xiaodong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2024.101077_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33004","article-title":"Assessment of food and drug administration\u2013 and European medicines agency\u2013approved systemic oncology therapies and clinically meaningful improvements in quality of life","volume":"4","author":"Arciero","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanwpc.2024.101077_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0363","article-title":"Patient experience captured by quality-of-life measurement in oncology clinical trials","volume":"3","author":"Haslam","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanwpc.2024.101077_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585530-000000000-00000","article-title":"Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond","volume":"4","author":"Baldwin","year":"2011","journal-title":"Patient"},{"key":"10.1016\/j.lanwpc.2024.101077_bib4","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S1470-2045(18)30097-4","article-title":"Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada","volume":"19","author":"Kluetz","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1359-6349(12)70023-X","article-title":"Health-Related Quality of Life in EORTC clinical trials \u2014 30 years of progress from methodological developments to making a real impact on oncology practice","volume":"10","author":"Velikova","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101953","article-title":"Analysis of patient-reported outcomes in the approval of novel oncology drugs in the United States, 2017\u20132022","volume":"59","author":"Ge","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanwpc.2024.101077_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.968272","article-title":"A\u00a0review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020","volume":"9","author":"Teixeira","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.lanwpc.2024.101077_bib8","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/ijc.31957","article-title":"Association between progression-free survival and patients' quality of life in cancer clinical trials","volume":"144","author":"Hwang","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib9","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/annonc\/mdy449","article-title":"Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016","volume":"29","author":"Marandino","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clgc.2019.07.007","article-title":"Quality-of-Life assessment and reporting in prostate cancer: systematic review of phase 3 trials testing anticancer drugs published between 2012 and 2018","volume":"17","author":"Marandino","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib11","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1016\/S1470-2045(19)30335-3","article-title":"US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017","volume":"20","author":"Fiero","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib12","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/ijc.34473","article-title":"The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020","volume":"152","author":"Gloy","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejca.2020.01.020","article-title":"Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015","volume":"129","author":"Gr\u00f6ssmann","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25973","article-title":"Overall survival benefits of cancer drugs approved in China from 2005 to 2020","volume":"5","author":"Zhang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanwpc.2024.101077_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2191-1991-3-15","article-title":"Health-related quality of life questionnaires in lung cancer trials: a systematic literature review","volume":"3","author":"Damm","year":"2013","journal-title":"Health Econ Rev"},{"key":"10.1016\/j.lanwpc.2024.101077_bib16","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","article-title":"International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium","volume":"21","author":"Coens","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.annonc.2022.12.004","article-title":"Methodological and reporting standards for quality-of-life data eligible for European society for medical oncology-magnitude of clinical benefit scale (ESMO-MCBS) credit","volume":"34","author":"Oosting","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/annonc\/mdv283","article-title":"Planning and reporting of quality-of-life outcomes in cancer trials","volume":"26","author":"Schandelmaier","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib19","article-title":"Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study","volume":"2","author":"Marandino","year":"2023","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib20","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S1470-2045(18)30418-2","article-title":"Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review","volume":"19","author":"Pe","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2017.09.011","article-title":"Patient-reported outcome measures (PROMs) in the management of lung cancer: a systematic review","volume":"113","author":"Bouazza","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jval.2023.01.017","article-title":"A\u00a0review of labeling based on patient-reported outcome endpoints for new oncology drugs approved by the European medicines agency (2017-2021)","volume":"26","author":"Gnanasakthy","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.lanwpc.2024.101077_bib24","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/annonc\/mdx191","article-title":"How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials","volume":"28","author":"Bonnetain","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib25","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/cncr.23968","article-title":"Cancer patient preferences for quality and length of life","volume":"113","author":"Meropol","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib26","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/S1470-2045(19)30656-4","article-title":"Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review","volume":"20","author":"Mierzynska","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib27","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ejso.2016.05.037","article-title":"The impact of treatment on quality of life of patients with head and neck cancer and its association with prognosis","volume":"42","author":"Carrillo","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejca.2017.12.023","article-title":"Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma","volume":"92","author":"Deng","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/bmj.317.7161.771","article-title":"Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews","volume":"317","author":"Silvestri","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.lanwpc.2024.101077_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamaoncol.2016.4166","article-title":"Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines","volume":"3","author":"Salas-Vega","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib31","article-title":"Associations with definitive outcomes and clinical benefit of cancer drugs at the time of marketing approval and in the postmarketing period","volume":"1\u20139","author":"Bujosa","year":"2021","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.lanwpc.2024.101077_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0895-4356(03)00044-1","article-title":"Defining clinically meaningful change in health-related quality of life","volume":"56","author":"Crosby","year":"2003","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib33","doi-asserted-by":"crossref","first-page":"e892","DOI":"10.1016\/S2352-3026(20)30292-1","article-title":"Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review","volume":"7","author":"Chakraborty","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.lanwpc.2024.101077_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/jnci\/djaa174","article-title":"Patient-reported outcomes in clinical trials leading to cancer immunotherapy drug approvals from 2011 to 2018: a systematic review","volume":"113","author":"Safa","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.lanwpc.2024.101077_bib35","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s00520-021-06724-6","article-title":"What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer","volume":"30","author":"Dunlop","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.lanwpc.2024.101077_bib36","article-title":"Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13","volume":"359","author":"Davis","year":"2017","journal-title":"BMJ"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T18:02:16Z","timestamp":1717437736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606524000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":35,"alternative-id":["S2666606524000713"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101077","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvements in the health-related quality-of-life benefit of cancer drugs approved in China, 2005\u20132020: an observational study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101077"}}